Postradiation changes in tissues: evaluation by imaging studies with emphasis on fluorodeoxyglucose-PET/computed tomography and correlation with histopathologic findings

PET Clin. 2014 Apr;9(2):217-35. doi: 10.1016/j.cpet.2013.10.005. Epub 2013 Dec 10.

Abstract

Efforts have been made to minimize the damage to adjacent normal tissues during radiotherapy, primarily by shifting from the use of conventional radiotherapy to more advanced techniques. Reviewing the overall pattern on combined anatomic and functional imaging can enhance diagnostic accuracy. Several radiotracers can be used; [(18)F]fluorodeoxyglucose is the most common. Familiarity with the type and timing of previous radiation therapy, the spectrum of imaging findings after radiation injury, and the appropriate use of the different radiotracers can be crucial. This article summarizes postradiation histologic findings and multimodality imaging findings, with emphasis on PET/computed tomography.

Keywords: Fluorodeoxyglucose; Positron emission tomography/computed tomography; Postradiation change; Radiation; Tissue necrosis; Tolerance dose.

Publication types

  • Review

MeSH terms

  • Bone and Bones / pathology
  • Bone and Bones / radiation effects
  • Brain / diagnostic imaging
  • Brain / pathology
  • Brain / radiation effects
  • Brain Neoplasms / radiotherapy
  • Fluorodeoxyglucose F18 / pharmacokinetics*
  • Gastrointestinal Tract / pathology
  • Gastrointestinal Tract / radiation effects
  • Humans
  • Lung / pathology
  • Lung / radiation effects
  • Magnetic Resonance Imaging
  • Multimodal Imaging
  • Necrosis / diagnostic imaging
  • Neoplasms / radiotherapy
  • Radiation Injuries / diagnostic imaging*
  • Radiation Injuries / pathology
  • Radionuclide Imaging
  • Radiopharmaceuticals / pharmacokinetics*
  • Radiotherapy / adverse effects
  • Spinal Cord / pathology
  • Spinal Cord / radiation effects
  • Tissue Distribution
  • Tomography, X-Ray Computed
  • Urinary Tract / pathology
  • Urinary Tract / radiation effects

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18